Norethisterone acetate
-
Norethisterone acetate
structure -
-
CAS No:
51-98-9
-
Formula:
C22H28O3
-
Chemical Name:
Norethisterone acetate
-
Synonyms:
19-Norpregn-4-en-20-yn-3-one,17-(acetyloxy)-,(17α)-;19-Nor-17α-pregn-4-en-20-yn-3-one,17-hydroxy-,acetate;(17α)-17-(Acetyloxy)-19-norpregn-4-en-20-yn-3-one;17-Acetoxy-19-nor-17α-pregn-4-en-20-yn-3-one;17α-Ethinyl-19-nortestosterone acetate;17β-Hydroxy-19-nor-17α-pregn-4-en-20-yn-3-one acetate;Norethindrone acetate;Norethisteron acetate;Norethisterone acetate;Norethynyltestosterone acetate;Norethysterone acetate;Norlutate;Norlutin acetate;17α-Ethynyl-19-nortestosterone acetate;17α-Ethinyl-19-nortestosterone 17β-acetate;17α-Ethinyl-4-estrene-17β-ol-acetate-3-one;17β-Acetoxy-19-nor-17α-pregn-4-en-20-yn-3-one;19-Norethynyltestosterone acetate;Norethindrone 17-acetate;19-Norethisterone acetate;17β-Acetoxy-17α-ethinyl-4-estren-3-one;Norlutin A;Orlutate;Primolut-Nor;SH 420;Norethisterone 17-acetate;Milli-Anovlar;Progylut;Gynophase;Gynovlane;Miniphase;Aygestin;Milligynon;NSC 22844;Estalis
- Categories:
-
CAS No:
Description
Norethindrone acetate is a female progestin approved by FDA for the treatment of endometriosis, uterine bleeding caused by abnormal hormone levels, and secondary amenorrhea.
Norethisterone acetate is a 3-oxo Delta(4)-steroid that is norethisterone in which the hydroxy group has been converted to its acetate ester. It has a role as a synthetic oral contraceptive and a progestin. It is a 3-oxo-Delta(4) steroid, a terminal acetylenic compound and an acetate ester. It derives from a norethisterone.|Norethindrone Acetate is the orally bioavailable acetate salt of norethindrone, a synthetic progestin with some anabolic, estrogenic, and androgenic activities. As do all progestins, norethindrone binds to and activates nuclear progesterone receptors (PRs) in target tissues such as the pituitary and reproductive system; ligand-receptor complexes are translocated to the nucleus where they bind to progesterone response elements (PREs) located on target genes, followed by various transcriptional events and histone acetylation. Physiological effects include the inhibition of luteinizing hormone (LH) release, an increase in the endometrial luteal-phase, and alterations in endocervical mucus secretion.|Acetate ester of norethindrone that is used as a long-term contraceptive (CONTRACEPTIVE AGENTS).
Norethisterone acetate Basic Attributes
340.46
340.46
200-132-0
9S44LIC7OJ
22844
DTXSID4023381
C702
H01CC54
2915299090
Characteristics
43.37000
3.99
1.1±0.1 g/cm3
161.5 °C
454.7±45.0 °C at 760 mmHg
197.1±28.8 °C
1.556
3.162mg/L(10 ºC)
dlt-mus-orl 1120 mg/kg/4W MUREAV 26,535,74
186.3 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Safety Information
NONH for all modes of transport
3
40-48
36/37
RC8965000
Xn
P281
H351
|Danger|H302 (15.93%): Harmful if swallowed [Warning Acute toxicity, oral]|P201, P202, P260, P261, P263, P264, P270, P271, P273, P280, P281, P301+P312, P302+P352, P304+P312, P304+P340, P308+P313, P312, P322, P330, P363, P391, P405, and P501|Aggregated GHS information provided by 113 companies from 9 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Treatment of endometriosis|Treatment of leiomyoma of uterus|Ryeqo is indicated for treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.
Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading. (See all compounds classified as Contraceptive Agents, Female.)|Contraceptive agents that act on the ENDOCRINE SYSTEM. (See all compounds classified as Contraceptive Agents, Hormonal.)
Aygestin
Norethisterone acetate Use and Manufacturing
Oral contraceptive (in combination with estrogen)
Human Drugs -> EU pediatric investigation plans|Human drugs -> Ryeqo -> EMA Drug Category|Pituitary and hypothalamic hormones and analogues -> Human pharmacotherapeutic group|Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients|Pharmaceuticals
Computed Properties
Molecular Weight:340.5
XLogP3:3.5
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:3
Exact Mass:340.20384475
Monoisotopic Mass:340.20384475
Topological Polar Surface Area:43.4
Heavy Atom Count:25
Complexity:695
Defined Atom Stereocenter Count:6
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Drug Function and Efficacy
Extract from the above information
Registered Holders
-
NAARI PTE LTD
Active
United States
-
STEROID SPA
Active
United States
-
Bayer Ag
Active
Finland
Recommended Suppliers of Norethisterone acetate
-
CN
5 YRS
Business licensedTrader Supplier of API,nutrition supplements,plant extract,peptide,HCGInquiryCAS No.: 51-98-9Grade: Top ProductContent: 98% -
CN
3 YRS
Business licensedTrader Supplier of vitaminInquiryCAS No.: 51-98-9Grade: Pharmaceutical GradeContent: 99% -
CN
5 YRS
Business licensedTrader Supplier of PVC resin,pvc paste resin,melamineInquiryCAS No.: 51-98-9Grade: Industrial GradeContent: 99% -
CN
3 YRS
Business licensedTrader Supplier of api,Intermediates,Organic Chemistry,Inorganic Chemistry,Daily Chemicals,Cosmetic Raw Materals,CATALYST AND AUXILIARY,FLAVORS AND FRAGRANCES,Chemical Pesticides,ADDITIVEInquiryCAS No.: 51-98-9Grade: Pharmaceutical GradeContent: 99%
Learn More Other Chemicals
-
Cyclooctenol, acetate
93981-85-2
-
Pyridinium, 1-[2-[[4-[2-(2,6-dichloro-4-nitrophenyl)diazenyl]phenyl]ethylamino]ethyl]-, acetate (1:1)
59709-07-8
-
(Z)-6-Nonen-1-yl acetate
76238-22-7
-
(2,4-dichloro-6-nitrophenyl) acetate Formula
37169-10-1
-
[Bis(2,2-dimethyl-1-aziridinyl)phosphinyl](ethoxycarbonyl)azanyl acetate Formula
54805-59-3
-
2-methylidenebutyl acetate Formula
55670-09-2
-
(3-acetyl-2,5-dioxo-4,4-diphenylimidazolidin-1-yl) acetate Structure
56775-94-1
-
[3-acetyloxy-2-[2-(cyclohexylamino)-2-oxoethyl]-1-benzofuran-6-yl] acetate Structure
60722-34-1
-
What is [3-acetyloxy-2-(2-amino-2-oxoethyl)-1-benzofuran-6-yl] acetate
60722-26-1
-
What is [3-[1-acetyloxy-2-(methylamino)ethyl]phenyl] acetate
63991-22-0